§ Funding Round
Series B funding round for Odyssey Therapeutics raising $170M in October 2022
Series B funding round for Odyssey Therapeutics raising $170M in October 2022
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
EQT Life Sciences | — | — |
| Organization | — | |
| Organization | — | |
General CatalystLEAD | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
SR One | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Fidelity Management & Research Company | — | — |
| Organization | — | |
HBM Healthcare Investments | — | — |
| Organization | — | |
Logos Capital | — | — |
T. Rowe Price Associates | — | — |
| Organization | — | |
| Organization | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$700M
Top Valuation
-
Odyssey Therapeutics raised $170M in a Series B round.
The round was announced on 10/01/22.
The round was led by General Catalyst.
